Obatoclax antagonizes Mcl-1 and induces cell death in hematological tumors [11,12], so we decided to study obatoclax effects in paclitaxel-sensitive and paclitaxel-resistant bladder cancer cells. The gene discussed is MCL1; the disease is urinary bladder carcinoma.